NCT04470037View on ClinicalTrials.gov

Multidisciplinary Study of Novel NMDA Modulation for Neurodegenerative Disorder

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

December 31, 2024

Study Completion Date

March 31, 2025

Conditions
Parkinson's Disease With Dementia
Interventions
DRUG

DAAOI-P

DAAOI-P 250-1500mg

DRUG

Placebo

starch pill

Trial Locations (1)

Unknown

RECRUITING

Department of Psychiatry, China Medical University Hospital, Taichung

All Listed Sponsors
collaborator

Ministry of Science and Technology, Taiwan

OTHER_GOV

lead

China Medical University Hospital

OTHER